Very long chain N4, N9-diacyl spermines: Non-viral lipopolyamine vectors for efficient plasmid DNA and siRNA delivery

Pharmaceutical Research

Volumn 26, Issue 1, 2009, Pages 19-31

  Ghonaim, Hassan M ^a   Li, Shi ^a   Blagbrough, Ian S ^a  

^a University of Bath   (United Kingdom)

Author keywords

Erucic acid; N4, N9 dioleoyl spermine; Primary skin cells; siRNA delivery; Very long chain fatty acid

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; N4,N9 DIACYLSPERMINE DERIVATIVE; N4,N9 DIARACHIDONOYL 1,12 DIAMINO 4,9 DIAZADODECANE; N4,N9 DIARACHIDOYL 1,12 DIAMINO 4,9 DIAZADODECANE; N4,N9 DIEICOSENOYL 1,12 DIAMINO 4,9 DIAZADODECANE; N4,N9 DIERUCOYL 1,12 DIAMINO 4,9 DIAZADODECANE; N4,N9 DINERVONOYL 1,12 DIAMINO 4,9 DIAZADODECANE; N4,N9 DIOLEOYL 1,12 DIAMINO 4,9 DIAZADODECANE; NANOPARTICLE; PLASMID DNA; SMALL INTERFERING RNA; SPERMINE DERIVATIVE; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID; DNA; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ETHIDIUM; FATTY ACID; FLUORESCENT DYE; GREEN FLUORESCENT PROTEIN; LIPOSOME; SPERMINE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ARTICLE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; OXIDATION; PRIORITY JOURNAL; STRUCTURE ANALYSIS; CELL LINE; CELL SURVIVAL; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; ELECTROCHEMISTRY; GENE AMPLIFICATION; GENETIC TRANSFECTION; GENETICS; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

CELL LINE; CELL SURVIVAL; DNA; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ETHIDIUM; FATTY ACIDS; FLUORESCENT DYES; GENE AMPLIFICATION; GREEN FLUORESCENT PROTEINS; HUMANS; INDICATORS AND REAGENTS; LIPOSOMES; MICROSCOPY, CONFOCAL; NANOPARTICLES; RNA, SMALL INTERFERING; SPERMINE; TETRAZOLIUM SALTS; THIAZOLES; TRANSFECTION;

EID: 57749173422     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9705-1     Document Type: Article

References (70)

1. W. J. Li F. C. Szoka 2007 Lipid-based nanoparticles for nucleic acid delivery Pharm. Res. 24 438 449
2. 9 -Dioleoyl spermine is a novel nonviral lipopolyamine vector for plasmid DNA formulation Pharm. Res. 22 972 980
3. 9 -dioctadecanoyl spermines: Nonviral lipopolyamine vectors for more efficient plasmid DNA formulation Pharm. Res. 23 31 40
4. I. S. Zuhorn J. B. F. N. Engberts D. Hoekstra 2007 Gene delivery by cationic lipid vectors: overcoming cellular barriers Eur. Biophys. J. Biophys. 36 349 362
5. L. Gaedtke J. Pelisek K. S. Lipinski C. J. Wrighton E. Wagner 2007 Transcriptionally targeted nonviral gene transfer using a β-catenin/TCF- dependent promoter in a series of different human low passage colon cancer cells Mol. Pharm. 4 129 139
6. S. J. Ryhanen V. M. J. Sally M. J. Parry P. Luciani G. Mancini J. M. I. Alakoskela P. K. J. Kinnunen 2006 Counterion-controlled transition of a cationic gemini from submicroscopic to giant vesicles J. Am. Chem. Soc. 128 8659 8663
7. F. Sansone M. Dudic G. Donofrio C. Rivetti L. Baldini A. Casnati S. Cellai R. Ungaro 2006 DNA condensation and cell transfection properties of guanidinium calixarenes: Dependence on macrocycle lipophilicity, size, and conformation J. Am. Chem. Soc. 128 14528 14536
8. H. Y. Li J. Birchall 2006 Chitosan-modified dry powder formulations for pulmonary gene delivery Pharm. Res. 23 941 950
9. J. P. Behr 1994 Gene-transfer with synthetic cationic amphiphiles-prospects for gene-therapy Bioconjug. Chem. 5 382 389
10. S. D. Li L. Huang 2006 Gene therapy progress and prospects: non-viral gene therapy by systemic delivery Gene Ther. 13 1313 1319
11. D. Hoekstra J. Rejman L. Wasungu F. Shi I. Zuhorn 2007 Gene delivery by cationic lipids: in and out of an endosome Biochem. Soc. Trans. 35 68 71
12. G. M. Puddu E. Cravero E. Ferrari A. Muscari P. Puddu 2007 Gene-based therapy for hypertension do preclinical data suggest a promising future? Cardiology 108 40 47
13. M. A. Behlke 2006 Progress towards in vivo use of siRNAs Mol. Ther. 13 644 670
14. A. Doody D. Putnam 2006 RNA-interference effectors and their delivery Crit. Rev. Ther. Drug Carrier Syst. 23 137 164
15. Y. Ikeda K. Taira 2006 Ligand-targeted delivery of therapeutic siRNA Pharm. Res. 23 1631 1640
16. C. X. Li A. Parker E. Menocal S. L. Xiang L. Borodyansky J. H. Fruehauf 2006 Delivery of RNA interference Cell Cycle 5 2103 2109
17. Z. Racz P. Hamar 2006 Can siRNA technology provide the tools for gene therapy of the future? Curr. Med. Chem. 13 2299 2307
18. K. A. Howard J. Kjems 2007 Polycation-based nanoparticle delivery for improved RNA interference therapeutics Expert Opin. Biol. Ther. 7 1811 1822
19. H. Takahashi D. Letourneur D. W. Grainger 2007 Delivery of large biopharmaceuticals from cardiovascular stents: A review Biomacromolecules 8 3281 3293
20. S. B. Zhang B. Zhao H. M. Jiang B. Wang B. C. Ma 2007 Cationic lipids and polymers mediated vectors for delivery of siRNA J. Control. Release 123 1 10
21. A. R. De Fougerolles 2008 Delivery vehicles for small interfering RNA in vivo Hum. Gene Ther. 19 125 132
22. K. F. Pirollo E. H. Chang 2008 Targeted delivery of small interfering RNA: Approaching effective cancer therapies Cancer Res. 68 1247 1250
23. M. Cristofanilli A. Iacoangeli I. A. Muslimov H. Tiedge 2006 Neuronal BC1 RNA: Microtubule-dependent dendritic delivery J. Mol. Biol. 356 1118 1123
24. V. Russ E. Wagner 2007 Cell and tissue targeting of nucleic acids for cancer gene therapy Pharm. Res. 24 1047 1057
25. K. Morimoto M. Kondo K. Kawahara H. Ushijima Y. Tomino M. Miyajima J. Kimura 2007 Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis Pharm. Res. 24 946 954
26. M. Hayes D. Drummond K. Hong W. Zheng V. Khorosheva J. Cohen C. Noble J. Park J. Marks C. Benz D. Kirpotin 2006 Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation Mol. Pharm. 3 726 736
27. P. E. Kish Y. Tsume P. Kijek T. M. Lanigan J. M. Hilfinger B. J. Roessler 2007 Bile acid-oligopeptide conjugates interact with DNA and facilitate transfection Mol. Pharm. 4 95 103
28. M. Walsh M. Tangney M. O'Neill J. Larkin D. Soden S. McKenna R. Darcy G. O'Sullivan C. O'Driscoll 2006 Evaluation of cellular uptake and gene transfer efficiency of pegylated poly-L-lysine compacted DNA: Implications for cancer gene therapy Mol. Pharm. 3 644 653
29. J. Y. Zhou J. W. Yockman S. W. Kim S. E. Kern 2007 Intracellular kinetics of non-viral gene delivery using polyethylenimine carriers Pharm. Res. 24 1079 1087
30. R. M. Schiffelers M. C. Woodle P. Scaria 2004 Pharmaceutical prospects for RNA interference Pharm. Res. 21 1 7
31. A. J. Geall I. S. Blagbrough 2000 Rapid and sensitive ethidium bromide fluorescence quenching assay of polyamine conjugate-DNA interactions for the analysis of lipoplex formation in gene therapy J. Pharm. Biomed. Anal. 22 849 859
32. J. P. Behr B. Demeneix J. P. Loeffler J. P. Mutul 1989 Efficient gene-transfer into mammalian primary endocrine-cells with lipopolyamine-coated DNA Proc. Natl. Acad. Sci. U. S. A. 86 6982 6986
33. J. S. Remy C. Sirlin P. Vierling J. P. Behr 1994 Gene-transfer with a series of lipophilic DNA-binding molecules Bioconjug. Chem. 5 647 654
34. H. W. Moser G. V. Raymond S. E. Lu L. R. Muenz A. B. Moser J. H. Xu R. O. Jones D. J. Loes E. R. Melhem P. Dubey L. Bezman N. H. Brereton A. Odone 2005 Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil Arch. Neurol. 62 1073 1080
35. P. L. Felgner Y. Barenholz J. P. Behr S. H. Cheng P. Cullis L. Huang J. A. Jessee L. Seymour F. Szoka A. R. Thierry E. Wagner G. Wu 1997 Nomenclature for synthetic gene delivery systems Hum. Gene Ther. 8 511 512
36. G. Ronsin C. Perrin P. Guedat A. Kremer P. Camilleri A. J. Kirby 2001 Novel spermine-based cationic gemini surfactants for gene delivery Chem. Commun. 2001 2234 2235
37. R. M. Tyrrell M. Pidoux 1986 Quantitative differences in host-cell reactivation of ultraviolet-damaged virus in human-skin fibroblasts and epidermal-keratinocytes cultured from the same foreskin biopsy Cancer Res. 46 2665 2669
38. M. Gossen H. Bujard 1992 Tight control of gene-expression in mammalian-cells by tetracycline-responsive promoters Proc. Natl. Acad. Sci. U. S. A. 89 5547 5551
39. D. Fischer T. Bieber Y. X. Li H. P. Elsasser T. Kissel 1999 A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity Pharm. Res. 16 1273 1279
40. M. C. O'Sullivan D. M. Dalrymple 1995 A one-step procedure for the selective trifluoroacetylation of primary amino-groups of polyamines Tetrahedron Lett. 36 3451 3452
41. D. Xu K. Prasad O. Repic T. J. Blacklock 1995 Ethyl trifluoroacetate - a powerful reagent for differentiating amino-groups Tetrahedron Lett. 36 7357 7360
42. A. J. Geall I. S. Blagbrough 2000 Homologation of polyamines in the rapid synthesis of lipospermine conjugates and related lipoplexes Tetrahedron 56 2449 2460
43. R. J. Bergeron J. S. McManis 1987 Total synthesis of (±)-15- deoxyspergualin J. Org. Chem. 52 1700 1703
44. S. A. Cryan A. Holohan R. Donohue R. Darcy C. M. O'Driscoll 2004 Cell transfection with polycationic cyclodextrin vectors Eur. J. Pharm. Sci. 21 625 633
45. J. Sen A. Chaudhuri 2005 Design, syntheses, and transfection biology of novel non- cholesterol-based guanidinylated cationic lipids J. Med. Chem. 48 812 820
46. H. S. Yoo J. E. Lee H. Chung I. C. Kwon S. Y. Jeong 2005 Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery J. Control. Release 103 235 243
47. V. A. Bloomfield 1997 DNA condensation by multivalent cations Biopolymers 44 269 282
48. C. F. Hung T. L. Hwang C. C. Chang J. Y. Fang 2005 Physicochemical characterization and gene transfection efficiency of lipid, emulsions with various co-emulsifiers Int. J. Pharm. 289 197 208
49. D. G. Anderson A. Akinc N. Hossain R. Langer 2005 Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters) Mol. Ther. 11 426 434
50. X. Gao L. Huang 1996 Potentiation of cationic liposome-mediated gene delivery by polycations Biochemistry 35 1027 1036
51. S. C. De Smedt J. Demeester W. E. Hennink 2000 Cationic polymer based gene delivery systems Pharm. Res. 17 113 126
52. J. Panyam V. Labhasetwar 2003 Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 329 347
53. J. H. Felgner R. Kumar C. N. Sridhar C. J. Wheeler Y. J. Tsai R. Border P. Ramsey M. Martin P. L. Felgner 1994 Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations J. Biol. Chem. 269 2550 2561
54. I. S. Blagbrough D. Al-Hadithi A. J. Geall 2000 Cheno-, urso- and deoxycholic acid spermine conjugates: Relative binding affinities for calf thymus DNA Tetrahedron 56 3439 3447
55. M. Ruponen P. Honkakoski M. Tammi A. Urtti 2004 Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer J. Gene Med. 6 405 414
56. C. M. Wiethoff J. G. Koe G. S. Koe C. R. Middaugh 2004 Compositional effects of cationic lipid/DNA delivery systems on transgene expression in cell culture J. Pharm. Sci. 93 108 123
57. A. Kichler A. J. Mason B. Bechinger 2006 Cationic amphipathic histidine-rich peptides for gene delivery Biochim. Biophys. Acta Biomembr. 1758 301 307
58. G. T. Hess W. H. Humphries N. C. Fay C. K. Payne 2007 Cellular binding, motion, and internalization of synthetic gene delivery polymers Biochim. Biophys. Acta 1773 1583 1588
59. F. D. Nascimento M. A. F. Hayashi A. Kerkis V. Oliveira E. B. Oliveira G. Radis-Baptista H. B. Nader T. Yamane I. L. dos Santos Tersariol I. Kerkis 2007 Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans J. Biol. Chem. 282 21349 21360
60. A. J. Geall M. A. W. Eaton T. Baker C. Catterall I. S. Blagbrough 1999 The regiochemical distribution of positive charges along cholesterol polyamine carbamates plays significant roles in modulating DNA binding affinity and lipofection FEBS Lett. 459 337 342
61. I. S. Blagbrough A. J. Geall A. P. Neal 2003 Polyamines and novel polyamine conjugates interact with DNA in ways that can be exploited in non-viral gene therapy Biochem. Soc. Trans. 31 397 406
62. N. Adjimatera T. Kral M. Hof I. S. Blagbrough 2006 Lipopolyamine-mediated single nanoparticle formation of calf thymus DNA analyzed by fluorescence correlation spectroscopy Pharm. Res. 23 1564 1573
63. C. McGregor C. Perrin M. Monck P. Camilleri A. J. Kirby 2001 Rational approaches to the design of cationic gemini surfactants for gene delivery J. Am. Chem. Soc. 123 6215 6220
64. G. Byk C. Dubertret V. Escriou M. Frederic G. Jaslin R. Rangara B. Pitard J. Crouzet P. Wils B. Schwartz D. Scherman 1998 Synthesis, activity, and structure-activity relationship studies of novel cationic lipids for DNA transfer J. Med. Chem. 41 224 235
65. J. K. Wang X. Guo Y. H. Xu L. Barron F. C. Szoka 1998 Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery J. Med. Chem. 41 2207 2215
66. J. A. Heyes D. Niculescu-Duvaz R. G. Cooper C. J. Springer 2002 Synthesis of novel cationic lipids: Effect of structural modification on the efficiency of gene transfer J. Med. Chem. 45 99 114
67. L. H. Lindner R. Brock D. Arndt-Jovin H. Eibl 2006 Structural variation of cationic lipids: Minimum requirement for improved oligonucleotide delivery into cells J. Control. Release 110 444 456
68. E. G. Saravolac O. Ludkovski R. Skirrow M. Ossanlou Y. P. Zhang C. Giesbrecht J. Thompson S. Thomas H. Stark P. R. Cullis P. Scherrer 2000 Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity J. Drug Target. 7 423 437
69. Y. P. Zhang L. Sekirov E. G. Saravolac J. J. Wheeler P. Tardi K. Clow E. Leng R. Sun P. R. Cullis P. Scherrer 1999 Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties Gene Ther. 6 1438 1447
70. K. W. C. Mok A. M. I. Lam P. R. Cullis 1999 Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties Biochim. Biophys. Acta Biomembr. 1419 137 150